Life-Cycle-Management

Indication extension and new applications for licensed products of RIEMSER Arzneimittel AG, particularly for dermatology, oncology and anti-infectiva indications.

Licencing

Oxoplatin

Oral chemotherapy for treatment at home with few side effects.

Research actinic ceratose

OxBue/OxHex

Human α-polymerase-inhibitor*

GXP Service

GMP

Production of samples pursuant international requirements

Research offers to third parties

GLP

Analyses of biological material from pre-clinical and clinical surveys.

GCP

Planning and execution of clinical surveys (incl. monitoring, data management and statistics)